Close Menu

aneuploidy

The results were presented at the ESHG meeting in Scotland this weekend and could potentially influence how NIPT is offered in those countries.

With evidence of significant variation among consent procedures in the NIPT space, and the potential for a lack of awareness about incidental findings, Bianchi recommends the field come together to standardize procedures and education.

In addition to offering NIPTs, Natera is eyeing the cancer diagnostics space.

The UK firm is using MALDI-TOF mass spec technology to develop the test as a screening tool for the disorder as early as eight weeks into a pregnancy.

Natera Raises $55.5M

The company said that the financing will go toward sales and marketing, as well as R&D on its Panorama NIPT, diagnostic tests for cancer, and clinical trials. 

Three new studies, published online in the New England Journal of Medicine, shed light on how NIPT may be best integrated into clinical care for all pregnant women.

The partners will work to establish Centrum Badan as the preferred testing partner for the NGS-based test in Poland, which had 376,000 live births last year.

The NextSeq CN500 sequencer was developed in collaboration with Illumina to offer clinical non-invasive prenatal testing for the Chinese market.

The method improves a research tool that can view chromosome movement throughout the living cell nucleus in space and time, and has both research and clinical uses.

Under the three-year project award, Premaitha and St George's plan to establish a UK Centre of Excellence for Prenatal Screening.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.